Your session is about to expire
← Back to Search
PITA for Heart Failure
Study Summary
This trial is testing a new treatment for heart failure called pacemaker induced transient dyssynchrony (PITA). This treatment involves using a pacemaker to purposely induce dyssynchrony (abnormal electrical impulse propagation) for several hours each day and then reversing this for the remainder of the time. The trial will test the feasibility, safety, and tolerability of PITA in humans with dilated cardiomyopathy. If successful, this study could lead to a larger study to assess the effectiveness of PITA in treating heart failure.
- Heart Failure
- Dilated Cardiomyopathy
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the aggregate population size that has joined this trial?
"Affirmative. According to the details posted on clinicaltrials.gov, this medical investigation has begun accepting participants since November 20th 2020 and is still looking for new candidates. They are targeting 8 individuals at a single site."
What is the principal goal of this clinical research initiative?
"As outlined by Medtronic, the main metric of success in this trial will be Tolerability as assessed via Sleep Quality and monitored over Baseline, Week 4, Week 8, and Week 12. Secondary objectives include quantifying dyssynchrony on echocardiography with an emphasis on interventricular/intraventricular discordance of QRS-complexes to peak pulmonary or aortic valve inflow >40 ms; septal-to-posterior wall motion delay higher than 130 milliseconds; onset/peak systolic velocity of opposing LV walls greater than 65ms; change in sodium levels ("
Are new participants welcomed for this medical trial?
"The evidence sourced from clinicaltrials.gov suggests that the recruitment process for this investigation is ongoing, having first been posted on November 20th 2020 and last updated on December 7th 2022."
Share this study with friends
Copy Link
Messenger